Skip to main content
Article thumbnail
Location of Repository

Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response

By Uwe Himmelreich, Richard Malik, Till Kühn, Heide-Marie Daniel, Ray L. Somorjai, Brion Dolenko and Tania C. Sorrell
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2004). A data-driven, flexible machine learning strategy for the classification of biomedical data.
  2. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations.
  3. (2000). Acute meningitis. In:
  4. (1992). Allgemeine Mikrobiologie.
  5. (1993). An introduction to the bootstrap.
  6. (1998). Cerebrospinal fluid and infections of the central nervous system.
  7. (1992). Cerebrospinal fluid in diseases of the nervous system.
  8. (2001). Characterization of intact microorganisms by MALDI mass spectrometry.
  9. (2004). Clinical features and prognostic factors in adults with bacterial meningitis.
  10. (2002). Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors.
  11. (1998). Community-acquired meningitis. Risk stratification for adverse clinical outcome and effect of antibiotic timing.
  12. (2005). Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid.
  13. (2001). Cryptococcomas distinguished from gliomas with magnetic resonance spectroscopy: an experimental rat and cell culture study.
  14. (1993). CSF and serum metabolic profile of patients with Hungington’s chorea: a study by high resolution proton NMR spectroscopy and HPLC.
  15. (2002). Dexamethasone in adults with bacterial meningitis.
  16. (1996). Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens.
  17. (2001). Discrimination, classification, identification of microorganisms using FTIR spectroscopy and chemometrics.
  18. (2002). Distinguishing normal from rejecting renal allografts: Application of a three stage classification strategy to MR and IR spectra of urine.
  19. (1998). Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy.
  20. (1989). High resolution proton magnetic resonance spectroscopy of biological fluids.
  21. (1987). High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid.
  22. (2003). Highthroughput characterisation of yeast mutants for functional genomics using metabolic footprinting.
  23. (2005). Human cerebrospinal fluid peptidomics.
  24. (2002). Identification of medically relevant microorganisms by vibrational spectroscopy.
  25. (2005). Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer’s disease.
  26. (2005). Identification of Staphylococcus aureus brain abscesses: rat and human studies with 1 H MR spectroscopy.
  27. (2003). Magnetic Resonance Spectroscopy of rat lung cryptococcomas identifies compounds of importance in pathogenesis.
  28. (2005). MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.
  29. (2005). Measuring the metabolome: current analytical technologies.
  30. (2007). Metabolic footprinting as a tool for discriminating between brewing yeasts.
  31. (2002). Metabolic profiling of rodent biological fluids via H-1 NMR spectroscopy using a 1 mm microlitre probe. Analyst 127: 582–584.
  32. (2005). Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study.
  33. (1998). Near-optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra.
  34. (2004). NMR spectroscopic determination of microbiological profiles in infectious diseases.
  35. (2003). Parallel analysis of transcript and metabolic profiles: a new approach in systems biology.
  36. (1994). Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis.
  37. (2005). Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children.
  38. (2005). Proton nuclear magnetic resonance - based metabonomics for rapid diagnosis of meningitis and ventriculitis.
  39. (2003). Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy.
  40. (2000). Stability of CSF metabolites measured by proton NMR.
  41. (1995). Standardized method for high resolution 1H-NMR of cerebrospinal fluid.
  42. (2003). The amyloid-beta (A beta) peptide pattern in cerebrospinal fluid in Alzheimer’s disease: evidence of a novel carboxyterminally elongated A beta peptide.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.